GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxd2 | rn6_v1_chr5_-_133709712_133709712 | 0.30 | 2.6e-08 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_+_95501778 Show fit | 64.03 |
ENSRNOT00000086805
|
secreted phosphoprotein 2 |
|
chr19_+_15081590 Show fit | 35.17 |
ENSRNOT00000024187
|
carboxylesterase 1F |
|
chr19_+_15081158 Show fit | 34.37 |
ENSRNOT00000074070
|
carboxylesterase 1F |
|
chr7_-_30105132 Show fit | 34.28 |
ENSRNOT00000091227
|
nuclear receptor subfamily 1, group H, member 4 |
|
chr4_-_176294997 Show fit | 33.91 |
ENSRNOT00000015112
ENSRNOT00000051461 ENSRNOT00000000026 ENSRNOT00000039877 ENSRNOT00000049303 |
kidney specific organic anion transporter |
|
chr14_+_85113578 Show fit | 32.79 |
ENSRNOT00000011158
|
nipsnap homolog 1 |
|
chr1_-_253000760 Show fit | 30.47 |
ENSRNOT00000030024
|
solute carrier family 16, member 12 |
|
chr6_+_80188943 Show fit | 24.64 |
ENSRNOT00000059335
|
melanoma inhibitory activity 2 |
|
chr6_-_127620296 Show fit | 21.70 |
ENSRNOT00000012577
|
serpin family A member 1 |
|
chr10_+_3411380 Show fit | 20.70 |
ENSRNOT00000004346
|
similar to RIKEN cDNA 2900011O08 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 53.8 | GO:0046849 | bone remodeling(GO:0046849) |
11.4 | 34.3 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
8.5 | 33.9 | GO:0051958 | methotrexate transport(GO:0051958) |
1.1 | 30.5 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.2 | 27.6 | GO:0019233 | sensory perception of pain(GO:0019233) |
4.1 | 24.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
7.2 | 21.7 | GO:0033986 | response to methanol(GO:0033986) |
5.2 | 20.7 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.7 | 20.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
2.9 | 20.4 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 69.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 68.2 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 55.3 | GO:0005615 | extracellular space(GO:0005615) |
1.0 | 34.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 32.6 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 30.9 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 30.1 | GO:0030426 | growth cone(GO:0030426) |
1.2 | 24.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 23.5 | GO:0005829 | cytosol(GO:0005829) |
0.4 | 20.7 | GO:0044295 | axonal growth cone(GO:0044295) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 54.3 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
8.6 | 34.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
8.5 | 33.9 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
1.0 | 32.8 | GO:0042165 | neurotransmitter binding(GO:0042165) |
1.5 | 30.5 | GO:0051184 | cofactor transporter activity(GO:0051184) modified amino acid transmembrane transporter activity(GO:0072349) |
0.0 | 28.8 | GO:0005509 | calcium ion binding(GO:0005509) |
4.1 | 24.6 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.2 | 21.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.5 | 18.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
3.5 | 17.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 34.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 29.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 15.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 13.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 12.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 11.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.6 | 11.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 7.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 7.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 5.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 22.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 21.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.7 | 20.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.5 | 20.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 18.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.9 | 18.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 17.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.4 | 15.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.8 | 11.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.1 | 11.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |